Search results
Astellas Pharma buys Iveric Bio for $5.9 bln
Reuters via Yahoo Finance· 1 year agoMay 1 (Reuters) - Japan's Astellas Pharma said on Monday it had fully acquired drugmaker IVERIC Bio Inc , through Berry Merger Sub, Inc, a wholly-owned subsidiary of Astellas US Holding, Inc ...
If You Invested $1000 in Activision Blizzard, Inc a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 1 year agoFor most investors, how much a stock's price changes over time is important. Not only can it impact...
CSTN Merger Sub, Inc. -- Moody's states that outages at CSTN's facility reduce the near-term...
Moody's via Yahoo Finance· 2 years agoAnnouncement: Moody's states that outages at CSTN's facility reduce the near-term potential for an upgradeGlobal Credit Research - 30 Aug 2022New York, August 30, 2022 -- Moody's Investors Service ...
Mr. Cooper (COOP) Prolongs Tender Offer for Home Point Buyout
Zacks via Yahoo Finance· 11 months agoMr. Cooper Group Inc. COOP extended the deadline of the tender offer to buy Home Point Capital...
Harley-Davidson spins off LiveWire in $1.8 billion SPAC merger
Reuters via Yahoo News· 2 years ago(Reuters) -Harley-Davidson Inc on Tuesday spun off its electric motorcycle division LiveWire in a...
Why SPAC Redwoods Acquisition Shares Are Skyrocketing Friday?
Benzinga via Yahoo Finance· 1 month agoRedwoods Acquisition Corp. (NASDAQ:RWOD) shares traded higher on Friday after the company announced...
Maxar (MAXR) Inches Closer to Takeover by Advent International
Zacks via Yahoo Finance· 1 year agoMaxar Technologies MAXR announced that it has obtained most of the regulatory approvals needed for...
Here's Why Builders FirstSource (BLDR) is a Strong Growth Stock
Zacks via Yahoo Finance· 1 year agoTaking full advantage of the stock market and investing with confidence are common goals for new and...
Marsh & McLennan (MMC) Focuses to Boost Hold in Australia
Zacks via Yahoo Finance· 1 year agoMarsh & McLennan's (MMC) sub-unit Mercer pursues twin growth-related initiatives to establish a...
UPDATE 1-Japan's Astellas Pharma agrees to buy IVERIC Bio for $5.9 bln
Reuters via Yahoo Finance· 1 year agoJapan's Astellas Pharma said on Monday it agreed to buy U.S.-based drugmaker IVERIC Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmology treatments ...